HIV care | Lenacapavir was the breakthrough drug in 2024
Due to its innovative mechanism and extended dosing
schedule, Lenacapavir has been described as a pathbreaking advancement in HIV
care and is ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.